BRO Quote, Financials, Valuation and Earnings

CorVel has a net margin of 23.9% compared to Brown & Brown's net margin of 10.43%. Brown & Brown's return on equity of 16.34% beat CorVel's return on equity of 33.19%.

Brown & Brown has a consensus price target of $119.31, signalling upside risk potential of 7.17%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Brown & Brown has higher upside potential than CorVel, analysts believe Brown & Brown is more attractive than CorVel.

Brown & Brown has a beta of 0.873, which suggesting that the stock is 12.658% less volatile than S&P 500. In comparison CorVel has a beta of 1.102, suggesting its more volatile than the S&P 500 by 10.208%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.5%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than CorVel quarterly revenues of $228M. Brown & Brown's net income of $331M is higher than CorVel's net income of $23.8M. Notably, Brown & Brown's price-to-earnings ratio is 31.01x while CorVel's PE ratio is 66.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.58x versus 6.71x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 23.9% compared to Brown & Brown's net margin of 30.93%. Brown & Brown's return on equity of 16.34% beat eHealth's return on equity of 1.6%.

Brown & Brown has a consensus price target of $119.31, signalling upside risk potential of 7.17%. On the other hand eHealth has an analysts' consensus of $10.00 which suggests that it could grow by 95.31%. Given that eHealth has higher upside potential than Brown & Brown, analysts believe eHealth is more attractive than Brown & Brown.

Brown & Brown has a beta of 0.873, which suggesting that the stock is 12.658% less volatile than S&P 500. In comparison eHealth has a beta of 1.113, suggesting its more volatile than the S&P 500 by 11.29%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.5%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than eHealth quarterly revenues of $315.2M. Brown & Brown's net income of $331M is higher than eHealth's net income of $97.5M. Notably, Brown & Brown's price-to-earnings ratio is 31.01x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.58x versus 0.28x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 12.92%. Brown & Brown's return on equity of 16.34% beat Kingstone Companies's return on equity of 38.66%.

Brown & Brown has a consensus price target of $119.31, signalling upside risk potential of 7.17%. On the other hand Kingstone Companies has an analysts' consensus of $19.00 which suggests that it could fall by -12.32%. Given that Brown & Brown has higher upside potential than Kingstone Companies, analysts believe Brown & Brown is more attractive than Kingstone Companies.

Brown & Brown has a beta of 0.873, which suggesting that the stock is 12.658% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.605, suggesting its less volatile than the S&P 500 by 39.519%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.5%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are larger than Kingstone Companies quarterly revenues of $42.1M. Brown & Brown's net income of $331M is higher than Kingstone Companies's net income of $5.4M. Notably, Brown & Brown's price-to-earnings ratio is 31.01x while Kingstone Companies's PE ratio is 15.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.58x versus 1.73x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 19.56%. Brown & Brown's return on equity of 16.34% beat Marsh & McLennan Companies's return on equity of 29.77%.

Brown & Brown has a consensus price target of $119.31, signalling upside risk potential of 7.17%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $233.06 which suggests that it could grow by 2.74%. Given that Brown & Brown has higher upside potential than Marsh & McLennan Companies, analysts believe Brown & Brown is more attractive than Marsh & McLennan Companies.

Brown & Brown has a beta of 0.873, which suggesting that the stock is 12.658% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.847, suggesting its less volatile than the S&P 500 by 15.285%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.5%. Marsh & McLennan Companies offers a yield of 1.44% to investors and pays a quarterly dividend of $0.82 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.4B, which are smaller than Marsh & McLennan Companies quarterly revenues of $7.1B. Brown & Brown's net income of $331M is lower than Marsh & McLennan Companies's net income of $1.4B. Notably, Brown & Brown's price-to-earnings ratio is 31.01x while Marsh & McLennan Companies's PE ratio is 27.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.58x versus 4.49x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.